Conduit Pharmaceuticals Inc.

NasdaqGM:CDT Stock Report

Market Cap: US$9.8m

Conduit Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CDT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Oct 24SellUS$393,439Nirland LimitedCompany3,808,000US$0.10
02 Oct 24SellUS$297,644Nirland LimitedCompany2,600,000US$0.12
17 Jul 24SellUS$4,249,062Corvus CapitalCompany13,911,248US$0.64
12 Jul 24SellUS$343,425Corvus CapitalCompany1,389,820US$0.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CDT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Individual Insiders5,958,6374.97%
Institutions9,406,7057.85%
Public Companies9,504,4657.93%
VC/PE Firms30,226,08125.2%
General Public64,762,75254%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.6%.

Top Shareholders

Top 25 shareholders own 45.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.2%
Corvus Capital
30,226,081US$2.5m0%no data
7.93%
AstraZeneca PLC
9,504,465US$779.4k0%no data
3.35%
Presidio Property Trust, Inc.
4,015,250US$329.3k0%100.0%
2.47%
Freda Lewis-Hall
2,958,287US$242.6k17.4%no data
1.67%
David Tapolczay
2,003,324US$164.3k0%no data
1.08%
A.G.P. / Alliance Global Partners Corp.
1,300,000US$106.6k0%0.3%
0.7%
Barclays PLC Private Banking & Investment Banking Investment
837,827US$68.7k3.15%no data
0.63%
BlackRock, Inc.
755,613US$62.0k9.7%no data
0.36%
Geode Capital Management, LLC
427,677US$35.1k4.46%no data
0.3%
The Vanguard Group, Inc.
361,711US$29.7k5.94%no data
0.29%
Chele Farley
351,510US$28.8k572%no data
0.28%
Faith Charles
341,594US$28.0k0%no data
0.27%
Qube Research & Technologies Ltd
318,359US$26.1k0%no data
0.17%
Simon Fry
200,000US$16.4k0%no data
0.16%
Citadel Advisors LLC
189,990US$15.6k0%no data
0.15%
Northern Trust Global Investments
184,837US$15.2k520%no data
0.15%
Morgan Stanley, Investment Banking and Brokerage Investments
183,579US$15.1k224%no data
0.14%
UBS Asset Management AG
168,594US$13.8k874%no data
0.074%
New York State Common Retirement Fund
88,700US$7.3k-9.58%no data
0.072%
State Street Global Advisors, Inc.
86,849US$7.1k2.36%no data
0.056%
Andrew Regan
66,650US$5.5k0%no data
0.044%
Charles Schwab Investment Management, Inc.
53,111US$4.4k0%no data
0.042%
Goldman Sachs Group, Investment Banking and Securities Investments
50,715US$4.2k153%no data
0.037%
Vanguard Personalized Indexing Management
44,317US$3.6k0%no data
0.034%
Societe Generale, Securities Investments
40,894US$3.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 09:45
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Conduit Pharmaceuticals Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution